id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0045-0004,FDA,FDA-2000-N-0045,Supplement from LaVerne Charpentier,Other,Supplement (SUP),2008-09-15T04:00:00Z,2008,9,2008-09-15T04:00:00Z,,2024-12-03T22:25:53Z,,0,0,09000064804af14d
FDA-2000-N-0045-0001,FDA,FDA-2000-N-0045,Laverne M. Charpentier; Final Debarment Order,Notice,N-Notice,2002-12-12T05:00:00Z,2002,12,2002-12-02T05:00:00Z,,2025-06-13T00:13:30Z,02-30482,0,0,09000064804af143
FDA-2000-N-0045-0002,FDA,FDA-2000-N-0045,Duplicate FR,Notice,,2002-12-12T00:00:00Z,2002,12,,,2024-12-03T22:23:36Z,,0,1,09000064804af151